Hideyuki Oki

1.3k total citations
30 papers, 941 citations indexed

About

Hideyuki Oki is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Hideyuki Oki has authored 30 papers receiving a total of 941 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Oncology and 9 papers in Organic Chemistry. Recurrent topics in Hideyuki Oki's work include Peptidase Inhibition and Analysis (7 papers), Phosphodiesterase function and regulation (6 papers) and Cholinesterase and Neurodegenerative Diseases (5 papers). Hideyuki Oki is often cited by papers focused on Peptidase Inhibition and Analysis (7 papers), Phosphodiesterase function and regulation (6 papers) and Cholinesterase and Neurodegenerative Diseases (5 papers). Hideyuki Oki collaborates with scholars based in Japan, United States and Russia. Hideyuki Oki's co-authors include Masakuni Kori, Susumu Tsunasawa, T.H. Tahirov, Tomitake Tsukihara, Kyoko Ogasahara, Katsuhide Yutani, Takashi Santou, Kenjiro Sato, Osamu Uchikawa and Haruhiko Kuno and has published in prestigious journals such as Journal of Molecular Biology, Journal of Medicinal Chemistry and Journal of Neurochemistry.

In The Last Decade

Hideyuki Oki

30 papers receiving 923 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hideyuki Oki Japan	21	593	283	224	128	105	30	941
William Seibel United States	22	943 1.6×	438 1.5×	176 0.8×	84 0.7×	97 0.9×	66	1.6k
Bernd Riedl Germany	20	684 1.2×	482 1.7×	148 0.7×	46 0.4×	161 1.5×	42	1.2k
Ross Weatherman United States	16	662 1.1×	338 1.2×	230 1.0×	68 0.5×	138 1.3×	25	1.3k
Mokdad Mezna United Kingdom	20	683 1.2×	161 0.6×	288 1.3×	73 0.6×	41 0.4×	38	1.1k
Esther Marco Spain	15	342 0.6×	225 0.8×	117 0.5×	86 0.7×	79 0.8×	28	789
Tamer S. Kaoud United States	27	1.2k 2.0×	468 1.7×	188 0.8×	88 0.7×	97 0.9×	68	1.7k
Roger J. Snow United States	19	655 1.1×	515 1.8×	281 1.3×	75 0.6×	80 0.8×	32	1.3k
Diane A. Trainor United States	17	529 0.9×	252 0.9×	175 0.8×	88 0.7×	58 0.6×	22	1.0k
Peter Kovar United States	19	612 1.0×	379 1.3×	261 1.2×	41 0.3×	51 0.5×	39	993
Karl F. Erhard United States	22	772 1.3×	262 0.9×	205 0.9×	100 0.8×	62 0.6×	43	1.4k

Countries citing papers authored by Hideyuki Oki

Since Specialization

Citations

This map shows the geographic impact of Hideyuki Oki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideyuki Oki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideyuki Oki more than expected).

Fields of papers citing papers by Hideyuki Oki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideyuki Oki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideyuki Oki. The network helps show where Hideyuki Oki may publish in the future.

Co-authorship network of co-authors of Hideyuki Oki

This figure shows the co-authorship network connecting the top 25 collaborators of Hideyuki Oki. A scholar is included among the top collaborators of Hideyuki Oki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideyuki Oki. Hideyuki Oki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Matsumoto, Shigemitsu, Shinji Morimoto, Masaki Daini, et al.. (2022). Design, synthesis, and structure–activity relationship of TAK-418 and its derivatives as a novel series of LSD1 inhibitors with lowered risk of hematological side effects. European Journal of Medicinal Chemistry. 239. 114522–114522. 13 indexed citations

Oki, Hideyuki, Hiroaki Yashiro, Ken‐ichi Hamagami, et al.. (2022). Design, Synthesis, and Biological Evaluation of a Novel Series of 4-Guanidinobenzoate Derivatives as Enteropeptidase Inhibitors with Low Systemic Exposure for the Treatment of Obesity. Journal of Medicinal Chemistry. 65(12). 8456–8477. 4 indexed citations

Matsuda, Satoru, Ryuji Yamada, Noriko Suzuki, et al.. (2021). LSD1 enzyme inhibitor TAK-418 unlocks aberrant epigenetic machinery and improves autism symptoms in neurodevelopmental disorder models. Science Advances. 7(11). 27 indexed citations

Adachi, Naruhiko, Toshio Moriya, Hideyuki Oki, et al.. (2021). Cryo-EM Structure of K+-Bound hERG Channel Complexed with the Blocker Astemizole. Structure. 29(3). 203–212.e4. 59 indexed citations

Matsuda, Satoru, Hideyuki Oki, Shinji Morimoto, et al.. (2018). T-448, a specific inhibitor of LSD1 enzyme activity, improves learning function without causing thrombocytopenia in mice. Neuropsychopharmacology. 44(8). 1505–1512. 38 indexed citations

Ito, Masahiro, Yoshihiro Ishibashi, Hideyuki Oki, et al.. (2017). Discovery and Characterization of a Eukaryotic Initiation Factor 4A-3-Selective Inhibitor That Suppresses Nonsense-Mediated mRNA Decay. ACS Chemical Biology. 12(7). 1760–1768. 30 indexed citations

Sakamoto, Kotaro, Yoshihiro Ishibashi, Ryutaro Adachi, et al.. (2017). Identification of cytidine-5-triphosphate synthase1-selective inhibitory peptide from random peptide library displayed on T7 phage. Peptides. 94. 56–63. 6 indexed citations

Mikami, Satoshi, Shinji Nakamura, Izumi Nomura, et al.. (2017). Discovery of Clinical Candidate N-((1S)-1-(3-Fluoro-4-(trifluoromethoxy)phenyl)-2-methoxyethyl)-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915): A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor for the Treatment of Cognitive Disorders. Journal of Medicinal Chemistry. 60(18). 7677–7702. 26 indexed citations

Nara, Hiroshi, Kenjiro Sato, Hideyuki Oki, et al.. (2016). Design, synthesis, and biological activity of novel, potent, and highly selective fused pyrimidine-2-carboxamide-4-one-based matrix metalloproteinase (MMP)-13 zinc-binding inhibitors. Bioorganic & Medicinal Chemistry. 24(23). 6149–6165. 27 indexed citations

10.

Yoshikawa, Masato, Takenori Hitaka, Tomoaki Hasui, et al.. (2016). Design and synthesis of potent and selective pyridazin-4(1H)-one-based PDE10A inhibitors interacting with Tyr683 in the PDE10A selectivity pocket. Bioorganic & Medicinal Chemistry. 24(16). 3447–3455. 7 indexed citations

11.

Tawada, Michiko, Yasuhiro Imaeda, Hideyuki Oki, et al.. (2016). Novel approach of fragment-based lead discovery applied to renin inhibitors. Bioorganic & Medicinal Chemistry. 24(22). 6066–6074. 6 indexed citations

12.

Yoshikawa, Masato, Haruhi Kamisaki, Jun Kunitomo, et al.. (2015). Design and synthesis of a novel 2-oxindole scaffold as a highly potent and brain-penetrant phosphodiesterase 10A inhibitor. Bioorganic & Medicinal Chemistry. 23(22). 7138–7149. 21 indexed citations

13.

Nara, Hiroshi, Kenjiro Sato, Hideyuki Mototani, et al.. (2014). Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: Highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1″ binding site. Bioorganic & Medicinal Chemistry. 22(19). 5487–5505. 37 indexed citations

14.

Miyamoto, Naoki, Nozomu Sakai, Takaharu Hirayama, et al.. (2013). Discovery of N-[5-({2-[(cyclopropylcarbonyl)amino]imidazo[1,2-b]pyridazin-6-yl}oxy)-2-methylphenyl]-1,3-dimethyl-1H-pyrazole-5-carboxamide (TAK-593), a highly potent VEGFR2 kinase inhibitor. Bioorganic & Medicinal Chemistry. 21(8). 2333–2345. 64 indexed citations

15.

Matsumoto, Shigemitsu, Naoki Miyamoto, Takaharu Hirayama, et al.. (2013). Structure-based design, synthesis, and evaluation of imidazo[1,2-b]pyridazine and imidazo[1,2-a]pyridine derivatives as novel dual c-Met and VEGFR2 kinase inhibitors. Bioorganic & Medicinal Chemistry. 21(24). 7686–7698. 48 indexed citations

16.

Iwata, Hidehisa, Hideyuki Oki, Kengo Okada, et al.. (2012). A Back-to-Front Fragment-Based Drug Design Search Strategy Targeting the DFG-Out Pocket of Protein Tyrosine Kinases. ACS Medicinal Chemistry Letters. 3(4). 342–346. 25 indexed citations

17.

Kimura, Haruhide, Yoshimi Sato, Hirobumi Suzuki, et al.. (2010). BTZO-1, a Cardioprotective Agent, Reveals that Macrophage Migration Inhibitory Factor Regulates ARE-Mediated Gene Expression. Chemistry & Biology. 17(12). 1282–1294. 20 indexed citations

18.

Oki, Hideyuki, Y. Matsuura, Hiroshi Komatsu, & A. A. Chernov. (1999). Refined structure of orthorhombic lysozyme crystallized at high temperature: correlation between morphology and intermolecular contacts. Acta Crystallographica Section D Biological Crystallography. 55(1). 114–121. 47 indexed citations

19.

Tahirov, T.H., Hideyuki Oki, Tomitake Tsukihara, et al.. (1998). Crystal structure of methionine aminopeptidase from hyperthermophile, Pyrococcus furiosus. Journal of Molecular Biology. 284(1). 101–124. 111 indexed citations

20.

Tahirov, T.H., Hideyuki Oki, Tomitake Tsukihara, et al.. (1998). High-Resolution Crystals of Methionine Aminopeptidase fromPyrococcus furiosusObtained by Water-Mediated Transformation. Journal of Structural Biology. 121(1). 68–72. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact